[Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D016670:Gabexate; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010195:Pancreatitis / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000008:administration & dosage*
D006146:Guanidines; D011480:Protease Inhibitors; D016670:Gabexate
Gabexat-Mesilat in der Therapie der akuten Pankreatitis. Multicenterstudie zur Verträglichkeit einer hohen intravenösen Dosis (4 g/Tag).